First Trust Advisors
SPPI

First Trust Advisors’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

First Trust Advisors’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-135,609
Closed -$2.28M – 2503
2018
Q3 		$2.28M Buy
135,609
+111,513
+463% +$2.41M ﹤0.01% 1599
2018
Q2 		$505K Buy
+24,096
New +$446K ﹤0.01% 2151
2015
Q4 		– Sell
-121,103
Closed -$724K – 2324
2015
Q3 		$724K Buy
+121,103
New +$841K ﹤0.01% 1841
2015
Q1 		– Sell
-49,528
Closed -$343K – 2323
2014
Q4 		$343K Buy
+49,528
New +$364K ﹤0.01% 2060

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

First Trust Advisors's SPPI Position: Q4 2018 in Review

First Trust Advisors sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2018, closing a stake of 135,609 shares — an estimated $2.28M sold.

First Trust Advisors first reported a position in SPPI in Q4 2014 and held it in 4 quarters. The position peaked at $2.28M in Q3 2018. 176 funds tracked by Wall St. Rank hold SPPI as of Q4 2018.

  • First Trust Advisors reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • First Trust Advisors sold 135,609 Spectrum Pharmaceuticals Inc shares in Q4 2018, an estimated $2.28M.
  • First Trust Advisors first reported a position in Spectrum Pharmaceuticals Inc in Q4 2014 and held it in 4 quarters.
  • First Trust Advisors's Spectrum Pharmaceuticals Inc position peaked at $2.28M in Q3 2018.
  • 176 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2018.

Based on First Trust Advisors's 13F filing for Q4 2018, filed 7 Feb 2019.